LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 110 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,721 | -52.4% | 37,359 | 0.0% | 0.00% | – |
| Q2 2023 | $85,552 | +7.7% | 37,359 | +14.3% | 0.00% | – |
| Q1 2023 | $79,415 | +27.2% | 32,681 | 0.0% | 0.00% | – |
| Q4 2022 | $62,421 | -20.4% | 32,681 | 0.0% | 0.00% | – |
| Q3 2022 | $78,434 | +60.1% | 32,681 | +24.0% | 0.00% | – |
| Q2 2022 | $49,000 | -24.6% | 26,351 | -14.9% | 0.00% | – |
| Q1 2022 | $65,000 | -43.5% | 30,980 | +6.2% | 0.00% | – |
| Q4 2021 | $115,000 | -10.9% | 29,176 | +8.4% | 0.00% | – |
| Q3 2021 | $129,000 | +4.0% | 26,907 | 0.0% | 0.00% | – |
| Q2 2021 | $124,000 | +3.3% | 26,907 | +31.9% | 0.00% | – |
| Q1 2021 | $120,000 | +57.9% | 20,400 | -7.6% | 0.00% | – |
| Q4 2020 | $76,000 | +300.0% | 22,086 | +70.9% | 0.00% | – |
| Q3 2020 | $19,000 | -26.9% | 12,922 | 0.0% | 0.00% | – |
| Q2 2020 | $26,000 | -39.5% | 12,922 | -41.1% | 0.00% | – |
| Q1 2020 | $43,000 | -52.7% | 21,927 | 0.0% | 0.00% | – |
| Q4 2019 | $91,000 | +75.0% | 21,927 | +26.6% | 0.00% | – |
| Q3 2019 | $52,000 | -52.3% | 17,314 | 0.0% | 0.00% | – |
| Q2 2019 | $109,000 | +13.5% | 17,314 | 0.0% | 0.00% | – |
| Q1 2019 | $96,000 | -16.5% | 17,314 | 0.0% | 0.00% | – |
| Q4 2018 | $115,000 | -37.8% | 17,314 | 0.0% | 0.00% | – |
| Q3 2018 | $185,000 | -11.1% | 17,314 | 0.0% | 0.00% | – |
| Q2 2018 | $208,000 | +23.1% | 17,314 | -12.3% | 0.00% | – |
| Q1 2018 | $169,000 | -98.4% | 19,748 | -98.1% | 0.00% | -100.0% |
| Q4 2017 | $10,503,000 | -26.1% | 1,063,011 | -8.1% | 0.02% | -29.0% |
| Q3 2017 | $14,215,000 | -1.3% | 1,156,689 | +32.1% | 0.03% | -3.1% |
| Q2 2017 | $14,403,000 | +39.6% | 875,577 | +21.7% | 0.03% | +33.3% |
| Q1 2017 | $10,314,000 | +43.7% | 719,232 | +38.7% | 0.02% | +41.2% |
| Q4 2016 | $7,175,000 | -23.4% | 518,738 | +0.1% | 0.02% | -5.6% |
| Q3 2016 | $9,367,000 | +22.6% | 518,352 | -2.6% | 0.02% | -5.3% |
| Q2 2016 | $7,638,000 | -14.9% | 532,302 | -29.2% | 0.02% | -13.6% |
| Q1 2016 | $8,979,000 | -8.0% | 751,335 | +2.5% | 0.02% | -8.3% |
| Q4 2015 | $9,759,000 | -5.7% | 733,210 | -23.9% | 0.02% | -7.7% |
| Q3 2015 | $10,345,000 | +6365.6% | 963,285 | +4744.3% | 0.03% | – |
| Q2 2015 | $160,000 | – | 19,885 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |